MGO One Seven’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.28M Sell
9,587
-693
-7% -$144K 0.04% 456
2026
Q1
$2.17M Sell
10,280
-1,286
-11% -$277K 0.04% 440
2025
Q4
$2.38M Buy
11,566
+312
+3% +$58.7K 0.05% 392
2025
Q3
$1.77M Buy
11,254
+719
+7% +$111K 0.04% 432
2025
Q2
$1.77M Sell
10,535
-1,444
-12% -$214K 0.06% 366
2025
Q1
$1.65M Buy
11,979
+8,263
+222% +$1.05M 0.06% 323
2024
Q4
$439K Buy
+3,716
New +$434K 0.02% 663
2024
Q2
Sell
-1,820
Closed -$204K 971
2024
Q1
$204K Sell
1,820
-335
-16% -$36.1K 0.01% 841
2023
Q4
$217K Buy
+2,155
New +$214K 0.01% 814
2023
Q3
Sell
-2,291
Closed -$217K 843
2023
Q2
$217K Buy
+2,291
New +$194K 0.02% 698
2021
Q1
Sell
-4,062
Closed -$218K 552
2020
Q4
$218K Buy
+4,062
New +$211K 0.04% 439
2019
Q1
Sell
-99
Closed -$4K 580
2018
Q4
$4K Buy
+99
New +$5.16K ﹤0.01% 1404
2018
Q1
$11K Sell
177
-42
-19% -$2.88K 0.01% 1061
2017
Q4
$13K Buy
+219
New +$13.5K 0.01% 994

Other funds holding CAH

MGO One Seven's CAH Position: Q2 2026 in Review

MGO One Seven reduced its Cardinal Health (CAH) stake by 6.7% in Q2 2026, selling an estimated $144K and leaving 9,587 shares worth $2.28M. The position accounts for 0.04% of the portfolio, ranked #456.

MGO One Seven first reported a position in CAH in Q4 2017 and has held it in 14 quarters since. The position peaked at $2.38M in Q4 2025. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • MGO One Seven held 9,587 shares of Cardinal Health worth $2.28M as of Q2 2026.
  • MGO One Seven sold 693 Cardinal Health shares in Q2 2026, an estimated $144K.
  • Cardinal Health made up 0.04% of MGO One Seven's portfolio in Q2 2026, its #456 holding.
  • MGO One Seven first reported a position in Cardinal Health in Q4 2017 and has held it in 14 quarters since.
  • MGO One Seven's Cardinal Health position peaked at $2.38M in Q4 2025.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on MGO One Seven's 13F filing for Q2 2026, filed 31 Jul 2026.